ZTS Zoetis Inc.

ZTS financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1555280 Exchange: NYSE SIC: 2834 (Pharmaceutical Preparations) Latest filing: 10-Q filed Aug 6, 2026 Data checked: Oct 21, 2026
Showing 3 of 15 annual and 0 of 58 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$69.23B (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Fiscal Year End
December (1231)
Phone
973-822-7000
EIN
460696167
Headquarters
PARSIPPANY, NJ, 07054
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$9.53B
Net Income
$2.64B
Total Assets
$15.08B
Total Equity
$3.15B
Total Debt
-
Free Cash Flow
$2.32B
Ratios
Gross Margin
71.7%
Net Margin
27.7%
Return on Equity
83.8%
Return on Assets
17.5%
Current Ratio
3.08x
FCF / Assets
15.4%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Zoetis Inc. generated $9.47B of revenue in fiscal 2025, with net income of $2.67B and an operating cash inflow of $2.90B. Revenue of $9.47B sets the scale for evaluating how effectively sales translated into profit and cash during the year. Compared with $9.26B in fiscal 2024, revenue recorded a 2.3% year-over-year increase. On a per-share basis, diluted EPS was $6.02, which connects the reported earnings outcome with the company’s diluted share count. Diluted EPS increased by 10.1% from $5.47 in fiscal 2024, showing how the earnings change reached shareholders on a per-share basis. Revenue equaled 0.61x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The first profit layer was $6.80B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 71.8%, so that share of each revenue unit remained after the cost of revenue reported for the period. After all reported below-operating-line items, the company recorded net income of $2.67B for the fiscal year. The final earnings result represented 28.2% of revenue, connecting the absolute net income figure with the company’s top-line scale. Pretax income was $3.36B, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. The pretax margin was 35.5%, relating income before taxes directly to revenue. Income tax expense totaled $687.00M, providing the reported tax component that separates pretax and after-tax earnings. Relative to pretax income, the tax provision measured 20.4%, quantifying the portion of pre-tax earnings paid in income tax. Net income equaled 80.2% of period-end equity, showing the earnings generated on shareholders’ book capital.

Liquidity and Capital Structure

The company held $15.47B of assets against $12.14B of liabilities and $3.33B of equity, revealing how the asset base was financed. At period end, current assets of $6.77B compared with current liabilities of $2.23B, defining the company’s short-term resource position. Current assets covered current liabilities by 3.03x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $2.31B, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 103.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Borrowings totaled $9.04B, adding a fixed financing obligation alongside the company’s equity capital. The debt-to-equity relationship was 2.71x, showing how much debt the company carried for each unit of book equity. The debt-to-assets relationship was 58.5%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 78.5%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 14.9%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $14.24B in fiscal 2024, the current asset base moved 8.6% and finished higher.

Cash Flow and Earnings Quality

Cash flow from operations was $2.90B, a reported cash inflow that can be compared directly with net income and capital spending. Operating cash flow equaled 1.09x of net income, showing how strongly accounting earnings converted into cash from operations. The cash-flow statement records $621.00M of capital expenditures, the investment amount considered after operating cash generation. Capital expenditures represented 21.4% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $2.28B, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 24.1%, showing how much sales converted into cash after investment. Measured against total assets, free cash flow represented 14.8%, showing the cash productivity of the company’s assets.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Zoetis Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $9.47B $9.26B $8.54B
Cost of Revenue $2.67B $2.72B $2.56B
Gross Profit $6.80B $6.54B $5.98B
OPERATING EXPENSES
R&D Expense $698.00M $686.00M $614.00M
SG&A Expense $2.38B $2.32B $2.15B
NON-OPERATING INCOME / EXPENSE
Interest Expense $222.00M $225.00M $239.00M
Other Income/Expense $-6.00M $-4.00M $-2.00M
Pretax Income $3.36B $3.13B $2.94B
Income Tax $687.00M $637.00M $596.00M
Net Income $2.67B $2.49B $2.34B
PER SHARE & SUPPLEMENTAL
Diluted EPS $6.02 $5.47 $5.07
Diluted Shares 443.84M 454.85M 462.27M
Depreciation & Amortization $487.00M $497.00M $491.00M
Balance Sheet
ASSETS
Cash & Equivalents $2.31B $1.99B $2.04B
Accounts Receivable $1.59B $1.32B $1.30B
Inventory $2.43B $2.31B $2.56B
Other Current Assets $436.00M $377.00M $434.00M
Current Assets $6.77B $5.99B $6.34B
PP&E (Net) $3.68B $3.39B $3.20B
Goodwill $2.77B $2.72B $2.76B
Intangible Assets $998.00M $1.13B $1.34B
Other Noncurrent Assets $328.00M $250.00M $206.00M
Noncurrent Assets $8.70B $8.25B $7.94B
Total Assets $15.47B $14.24B $14.29B
LIABILITIES
Accounts Payable $487.00M $433.00M $411.00M
Short-term Debt $0 $1.35B $0
Other Current Liabilities $107.00M $125.00M $102.00M
Current Liabilities $2.24B $3.41B $1.89B
Long-term Debt $9.04B $5.22B $6.56B
Other Noncurrent Liabilities $248.00M $222.00M $237.00M
Noncurrent Liabilities $9.90B $6.06B $7.41B
Total Liabilities $12.14B $9.47B $9.30B
EQUITY
Common Stock $5.00M $5.00M $5.00M
Additional Paid-in Capital $1.10B $1.18B $1.13B
Retained Earnings $13.74B $11.97B $10.30B
Accumulated OCI $-834.00M $-940.00M $-839.00M
Total Equity $3.33B $4.77B $4.99B
Total Liabilities & Equity $15.47B $14.24B $14.29B
SUPPLEMENTAL
Total Debt $9.04B $6.57B $6.56B
Shares Outstanding 424.93M 448.47M 458.37M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $2.90B $2.95B $2.35B
Capital Expenditures $621.00M $655.00M $732.00M
Cash from Investing $-748.00M $-315.00M $-777.00M
Cash from Financing $-1.87B $-2.66B $-3.11B
Free Cash Flow $2.28B $2.30B $1.62B
Beginning Cash (CFS) $1.99B $2.04B $3.58B
Net Change in Cash $286.00M $-22.00M $-1.53B
Effect of FX on Cash $39.00M $-32.00M $-7.00M
Calculated Ending Cash $2.31B $1.99B $2.04B
Cash per BS $2.31B $1.99B $2.04B
Cash scope difference (CFS − BS) - - -
Cash per CFS $2.31B $1.99B $2.04B

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Zoetis Inc.'s annual revenue?

Zoetis Inc. reported $9.53B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Zoetis Inc. profitable?

Yes. Zoetis Inc. reported $2.64B in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does Zoetis Inc. generate free cash flow?

Yes. Free cash flow was $2.32B for trailing twelve months. Operating cash flow was $2.84B.